Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04201132 · ClinicalTrials.gov registry record · NA
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
A NA study of Carotid Stenosis and Carotid Artery Diseases, sponsored by Contego Medical.
- Active
- Registry status
- NA
- Development phase
- 305
- Enrollment target
- 20
- Study locations
NCT04201132 is a NA study of Carotid Stenosis and Carotid Artery Diseases that is active but no longer recruiting, run by Contego Medical. The registered enrollment target is 305 participants, below the 572-participant average among 11 other Carotid Stenosis trials with a reported enrollment target (47% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT04201132, a NA study of Carotid Stenosis and Carotid Artery Diseases, is active but no longer recruiting, sponsored by Contego Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 305 participants
- Enrollment target
- 20
- Study locations
Study Summary
A prospective, multicenter single-arm, open label study to evaluate the safety and effectiveness of the Neuroguard IEP System for the treatment of carotid artery stenosis in subjects at elevated risk for adverse events following carotid endarterectomy (CEA).
Conditions Studied
Interventions
- DEVICE Carotid artery stenting with Neuroguard IEP System
Study Locations (20)
Pennsylvania
- St. Vincent Hospital - Erie
- UPMC Hamot - Erie
- Pinnacle Health Cardiovascular Institute - Harrisburg
- Lankenau Institute - Wynnewood
New York
- University at Buffalo Neurosurgery - Buffalo
- Mt. Sinai - New York
- Stony Brook University Medical Center - Stony Brook
Florida
- Manatee Memorial Hospital - Bradenton
- Lyerly Baptist Neurosurgery - Jacksonville
Alabama
- Huntsville Hospital - Huntsville
California
- St. Helena Hospital - St. Helena
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Iowa
- University of Iowa Hospital and Clinics - Iowa City
Kentucky
- University of Lexington - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 305 participants |
| Start Date | 2020-06-12 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04201132
The ClinicalTrials.gov registry entry for NCT04201132 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 572-participant average among 11 other Carotid Stenosis trials with a reported enrollment target (47% lower). The listed sponsor is Contego Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Carotid Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Carotid artery stenting with Neuroguard IEP System is the first listed.
NCT04201132 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Pennsylvania, New York, Florida.
Frequently Asked Questions
What is clinical trial NCT04201132 about?
NCT04201132 is a clinical study titled "Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System". A prospective, multicenter single-arm, open label study to evaluate the safety and effectiveness of the Neuroguard IEP System for the treatment of carotid artery stenosis in subjects at elevated risk for adverse events following carotid endarterectomy (CEA).
What is the current status of trial NCT04201132?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 305 participants. The study started on 2020-06-12. Estimated completion is 2025-12.
What conditions does trial NCT04201132 study?
This clinical trial studies the following conditions: Carotid Stenosis, Carotid Artery Diseases, Carotid Artery Stenosis.
What interventions are being tested in trial NCT04201132?
The interventions under investigation include: Carotid artery stenting with Neuroguard IEP System (DEVICE).
Who is sponsoring clinical trial NCT04201132?
This trial is sponsored by Contego Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04201132 being conducted?
This trial has 20 study locations across Alabama, California, District of Columbia, Florida, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carotid Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients
ACTIVE NOT RECRUITING · NA
-
Transcutaneous ARFI Ultrasound for Differentiating Carotid Plaque With High Stroke Risk
ACTIVE NOT RECRUITING · NA
-
Remote Ischemic Preconditioning for Carotid Endarterectomy
COMPLETED · NA
-
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
COMPLETED · NA
-
Symptomatic Carotid Outcomes Registry
ACTIVE NOT RECRUITING
-
Cost-Effectiveness of a Specialized Ultrasound Instrument to Diagnose Carotid Stenosis as a Way to Reduce the Risk of Stroke
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.